Registration and Breakfast

2008 Trends in the Global Biotechnology Industry

Ian Oliver, Senior Manager Ernst & Young – Annual Biotech Report

Finding the Roadmap to Success

Given the current financial climate, do investors still have funds to invest in the biotech industry, and how is the downturn affecting their decisions? We hear from both European and American based venture capital companies and an investment bank on how they are looking at funding companies now and in the future.

Chairing the session:
Dr Fraser Campbell, Associate Director, Grant Thornton, Capital Markets

• Mr David Mott, General Partner, New Enterprise Associates (NEA)
• Mr Antoine Papiernik, Managing Partner, Sofinnova Partners
• Dr John Shields, Principal, Abingworth Management LLP

Lunch

How Are Large Pharma Acquiring Technology?

With the IPO window seemingly shut, we invite four senior executives from large pharma who analyse, recommend and make decisions within their organisations, to discuss how they are considering acquiring new technologies.

Chairing the session:

Mr Tim Haines, Partner, Abingworth Manangement LLP

• Dr Kevin Lee, VP, Epigenetics & Pathway Control GlaxoSmithKline
• Dr Margaret Beer, Director Licensing and External Research, Merck Sharp and Dohme
• Dr Ruth Keir, Executive Director, Pfizer
  Dr Graeme Martin, CEO, Takeda Research Investment Inc

Afternoon Break

Personalised Medicine and Healthcare

Recent technological developments, political and economic priorities and the drive towards patient-centred care have accelerated the pace of personalisation of healthcare services.

In this session the panel cover issues that are considered by the Nuffield Council on BioEthics and we see presentations and hear debate from an industry representative, patient group and academia, focus on personalised medicine and artificial intelligence.

Chairing the session:

Professor Nigel Cameron, President, Center for Policy in Emerging Technologies

• Dr Harald Schimdt, Assistant Director, Nuffield Council on Bioethics
• Dr Kieran Breen, R&D Director, Parkinson’s Disease Society
• Prof. Barbara Sahakian, Clinical Neuropsychology, University of Cambridge

Networking Dinner at Murrays

Join us for dinner at the Wellcome Trust Genome Campus Restaurant – Murrays